Cyber warfare.

This incendiary randomized trial demonstrates that men with prostate cancer were significantly more likely to prefer CyberKnife treatment when exposed to a CyberKnife advertisement without (68%) or with (68%) a disclaimer than to no (23%) or medically “accurate” (46%) information. | Caputo, Prostate Cancer Prostatic Dis 2020